Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Guilin QIAO"'
Publikováno v:
Shiyou shiyan dizhi, Vol 44, Iss 4, Pp 593-602 (2022)
The genesis of carbonate reservoirs of the Lower-Middle Ordovician strata has been an important topic for petroleum exploration in the Yubei area, Tarim Basin. To investigate the stages and properties of paleo-fluid and discuss the reservoir origin,
Externí odkaz:
https://doaj.org/article/efcc866d84c5406ab7977e2b56f74a25
E3 Ubiquitin Ligase Cbl-b Suppresses Proallergic T Cell Development and Allergic Airway Inflammation
Autor:
Guilin Qiao, Haiyan Ying, Yixia Zhao, Yanran Liang, Hui Guo, Huifeng Shen, Zhenping Li, Julian Solway, Enxiang Tao, Y. Jeffrey Chiang, Stanley Lipkowitz, Josef M. Penninger, Wallace Y. Langdon, Jian Zhang
Publikováno v:
Cell Reports, Vol 6, Iss 4, Pp 709-723 (2014)
E3 ubiquitin ligase Cbl-b has emerged as a gatekeeper that controls the activation threshold of the T cell antigen receptor and maintains the balance between tolerance and autoimmunity. Here, we report that the loss of Cbl-b facilitates T helper 2 (T
Externí odkaz:
https://doaj.org/article/47d1fa5e69ba4bec879466f4c8fe9c8f
Autor:
Hui Guo, Guilin Qiao, Haiyan Ying, Zhenping Li, Yixia Zhao, Yanran Liang, Lifen Yang, Stanley Lipkowitz, Josef M. Penninger, Wallace Y. Langdon, Jian Zhang
Publikováno v:
Cell Reports, Vol 1, Iss 5, Pp 472-482 (2012)
E3 ubiquitin ligase Cbl-b plays a crucial role in T cell activation and tolerance induction. However, the molecular mechanism by which Cbl-b inhibits T cell activation remains unclear. Here, we report that Cbl-b does not inhibit PI3K but rather suppr
Externí odkaz:
https://doaj.org/article/16a2de138b5249439783100580902abf
Autor:
Ajay V. Maker, Bellur S. Prabhakar, Steven A. Rosenberg, Yang-Xin Fu, Peter Gann, Dolores L. Mahmud, Jed F. Calata, Nicholas Kunda, Jianzhong Qin, Guilin Qiao
The majority of patients with colon cancer will develop advanced disease, with the liver being the most common site of metastatic disease. Patients with increased numbers of tumor-infiltrating lymphocytes in primary colon tumors and liver metastases
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d3d7b75dc04f49e27612a314552c004
https://doi.org/10.1158/0008-5472.c.6509364.v1
https://doi.org/10.1158/0008-5472.c.6509364.v1
Autor:
Ajay V. Maker, Bellur S. Prabhakar, Steven A. Rosenberg, Yang-Xin Fu, Peter Gann, Dolores L. Mahmud, Jed F. Calata, Nicholas Kunda, Jianzhong Qin, Guilin Qiao
Supplemental Figure Legend from LIGHT Elevation Enhances Immune Eradication of Colon Cancer Metastases
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b8e53309ac9e808e7e3495d86016a9a
https://doi.org/10.1158/0008-5472.22415712
https://doi.org/10.1158/0008-5472.22415712
Autor:
Ajay V. Maker, Bellur S. Prabhakar, Steven A. Rosenberg, Yang-Xin Fu, Peter Gann, Dolores L. Mahmud, Jed F. Calata, Nicholas Kunda, Jianzhong Qin, Guilin Qiao
Supplemental figure 1 presents proliferation, apoptosis, and migration assays demonstrating that LIGHT expressing colon cancer cell lines maintain wild-type characteristics. Supplemental figure 2 provides evidence that LIGHT expressing colorectal liv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07eceba0b6051845668dffa3576accc8
https://doi.org/10.1158/0008-5472.22415709
https://doi.org/10.1158/0008-5472.22415709
Publikováno v:
J Surg Res
INTRODUCTION: The generation of long-term durable tumor immunity and prolonged disease-free survival depends on the ability to generate and support CD8+ central memory T-cells. Microsatellite-stable colon cancer is resistant to currently available im
Autor:
Guilin Qiao, Lyonell B. Kone, Evan H. Phillips, Steve Seung-Young Lee, Grace E. Brown, Salman R. Khetani, Archana Thakur, Lawrence G. Lum, Bellur S. Prabhakar, Ajay V. Maker
Publikováno v:
Oncogene, vol 41, iss 14
Abstract Increased tumor infiltrating lymphocytes (TIL) are associated with improved patient responses to immunotherapy. As a result, there is interest in enhancing lymphocyte trafficking particularly to colon cancers since the majority are checkpoin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23b8d50a80b1cfc44b4710d9066f829d
https://escholarship.org/uc/item/3jp0n9v9
https://escholarship.org/uc/item/3jp0n9v9
Autor:
Bellur S. Prabhakar, Guilin Qiao, Ajay V. Maker, Lakshmi Sripada, Nicholas Kunda, Shikha Saini, Kiara A. Tulla
Publikováno v:
Endocrine-Related Cancer. 26:551-563
ATC is an aggressive disease with limited therapeutic options due to drug resistance. TRAIL is an attractive anti-cancer therapy that can trigger apoptosis in a cancer cell-selective manner. However, TRAIL resistance is a major clinical obstacle for
Autor:
Guilin, Qiao, Lyonell B, Kone, Evan H, Phillips, Steve Seung-Young, Lee, Grace E, Brown, Salman R, Khetani, Archana, Thakur, Lawrence G, Lum, Bellur S, Prabhakar, Ajay V, Maker
Publikováno v:
Oncogene. 41(14)
Increased tumor infiltrating lymphocytes (TIL) are associated with improved patient responses to immunotherapy. As a result, there is interest in enhancing lymphocyte trafficking particularly to colon cancers since the majority are checkpoint blockad